AlloHSCT for R/R LBCL after CAR-T therapy failure VJHemOnc – Video Journal of Hematology & HemOnc 3:44 2 years ago 204 Далее Скачать
The role of alloSCT for R/R LBCL in the era of CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 0:44 1 year ago 118 Далее Скачать
How does CAR T-cell therapy compare with allo-SCT for treating R/R LBCL? Lymphoma Hub 7:21 1 year ago 81 Далее Скачать
CAR-T therapy for R/R aggressive B-cell NHL VJHemOnc – Video Journal of Hematology & HemOnc 4:05 3 years ago 70 Далее Скачать
Management of relapse after CAR-T in patients with B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:33 3 years ago 172 Далее Скачать
Risks and indications for consolidation alloHSCT after CAR T-cell therapy in ALL VJHemOnc – Video Journal of Hematology & HemOnc 4:24 3 years ago 54 Далее Скачать
CAR-T therapy vs autologous transplantation in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:06 2 years ago 196 Далее Скачать
Limitations of CAR T-cell therapy for DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:20 3 years ago 458 Далее Скачать
The value of CAR-T cell therapy for the treatment of R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:00 2 years ago 289 Далее Скачать
How long do CAR-T Cells work? #myeloma HealthTree University for Multiple Myeloma 3:51 2 years ago 1 515 Далее Скачать
Risk factors to predict post-CD19 CAR-T cell therapy outcomes in patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:05 1 year ago 185 Далее Скачать
Overcoming challenges in CAR T-cell therapy for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:04 9 months ago 428 Далее Скачать
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy International Academy for Clinical Hematology IACH 48:12 1 year ago 273 Далее Скачать
Treatment options for patients with DLBCL who relapse after CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 year ago 635 Далее Скачать
Side Effects of CAR T Cell Therapy HealthTree University for Multiple Myeloma 1:00 1 year ago 9 632 Далее Скачать
Managing relapse post-CAR-T therapy in DLBCL & the need to change clinical trial inclusion criteria VJHemOnc – Video Journal of Hematology & HemOnc 3:55 2 years ago 197 Далее Скачать
Management of relapse after CAR-T VJHemOnc – Video Journal of Hematology & HemOnc 3:28 3 years ago 249 Далее Скачать
Will CAR T-cell therapy become standard of care for patients with R/R DLBCL? Lymphoma Hub 4:37 5 years ago 102 Далее Скачать
Updates on HBI0101, a CAR T-cell therapy, for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:23 3 weeks ago 91 Далее Скачать
